The company's weight loss drug, Belviq, is expected to launch nationally any day now.
Three or four positive catalysts will move the share price higher.
Get in before it gaps higher.
Read the recent Yahoo headline news.
Back to the most recent high of $11.05 by Friday is realistic.
Higher on D.E.A. news and a Belviq launch.
It would be very easy for Eisai to have another Japanese company make a lower offer to allow Eisai to then come in with a higher offer.
I recall Cramer was saying to sell just before the run-up occurred.
He cost a lot of individuals 1,000% profits.
First revenue report from the company's Tarantula site in Arizona is due out at any time.
The company's C.E.O. was a director at the U.S. Mint in his previous position.
Visit the company's website to view pictures/video of the production process.
The company's patented MANF technology could hold a cure for a number of neurological diseases such as Parkinson's Disease and Alzheimer's Disease.
Read the recent Yahoo news.
Currently trading under a dime.